October 8, 2024 12:00 PM EDT
Pharma
Law
Health Tech

Com­pound­ing phar­ma­cy group sues FDA for end­ing Eli Lil­ly's GLP-1 drug short­age

Shelby Livingston

Senior health tech reporter

A trade group for large com­pound­ing phar­ma­cies sued the FDA over its move to take Eli Lil­ly’s block­buster GLP-1 drug off its short­age list, ham­string­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times